Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) General Counsel Philip Mazzara sold 42,000 shares of the company’s stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $96.56, for a total transaction of $4,055,520.00. Following the completion of the sale, the general counsel now owns 258,564 shares of the company’s stock, valued at approximately $24,966,939.84. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Philip Mazzara also recently made the following trade(s):
- On Wednesday, October 9th, Philip Mazzara sold 25,000 shares of Astera Labs stock. The stock was sold at an average price of $60.74, for a total value of $1,518,500.00.
- On Monday, August 26th, Philip Mazzara sold 8,000 shares of Astera Labs stock. The stock was sold at an average price of $43.12, for a total value of $344,960.00.
- On Friday, August 23rd, Philip Mazzara sold 42,090 shares of Astera Labs stock. The shares were sold at an average price of $40.43, for a total transaction of $1,701,698.70.
Astera Labs Trading Down 1.6 %
Shares of ALAB stock opened at $90.75 on Wednesday. Astera Labs, Inc. has a 52-week low of $36.22 and a 52-week high of $100.09. The business’s fifty day moving average is $60.03 and its 200 day moving average is $58.84.
Analysts Set New Price Targets
ALAB has been the topic of a number of recent research reports. Evercore ISI dropped their price target on Astera Labs from $98.00 to $80.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. Morgan Stanley lifted their target price on shares of Astera Labs from $74.00 to $94.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. JPMorgan Chase & Co. upped their price target on shares of Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Needham & Company LLC reissued a “buy” rating and set a $65.00 target price on shares of Astera Labs in a report on Wednesday, October 9th. Finally, Craig Hallum raised their price target on Astera Labs from $75.00 to $105.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Eleven investment analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of “Buy” and an average target price of $92.36.
View Our Latest Report on ALAB
Hedge Funds Weigh In On Astera Labs
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. bought a new stake in shares of Astera Labs during the 1st quarter worth $127,268,000. Westfield Capital Management Co. LP purchased a new position in shares of Astera Labs in the 3rd quarter worth about $52,049,000. Price T Rowe Associates Inc. MD bought a new position in shares of Astera Labs during the 1st quarter valued at about $44,514,000. Capital World Investors purchased a new position in shares of Astera Labs during the 1st quarter valued at about $44,514,000. Finally, Bamco Inc. NY bought a new stake in Astera Labs in the 1st quarter worth approximately $37,095,000.
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Stories
- Five stocks we like better than Astera Labs
- What is an Earnings Surprise?
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- ESG Stocks, What Investors Should Know
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.